Cubit Lifesciences Llp - Due diligence report

A 360° intelligence report on Cubit Lifesciences: trust score, financial health, credit view, compliance, directors, growth and distress sig…

2018-06-28 Ahmedabad, Gujarat Active
Share
Connect MCP
CL Cubit Lifesciences Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cubit Lifesciences — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Cubit Lifesciences is assessed as Low Risk with a Trust Score of 77/100. Cubit Lifesciences is an active limited liability partnership incorporated in 2018, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 24 Jul 2026 from the latest processed filings. Cubit Lifesciences Llp snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 2 open (49.96 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India2 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHOK KUMAR AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
PRABHAT AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
SHALINI RAVI AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
PRIYANKA PRABHAT AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
RAVI ASHOKKUMAR AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • RAVI ASHOKKUMAR AGRAWAL has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 75
Growth signals & trust indicators
EPFO headcount growing - hiring signal.
Operating for 8 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 49.96 cr already registered.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 11 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
24 Aug 2023
Director appointed
RAVI ASHOKKUMAR AGRAWAL (Designated Partner)
04 May 2019
Charge created
State Bank Of India - 24.98 cr
03 May 2019
Charge created
State Bank Of India - 24.98 cr
19 Feb 2019
Director ceased
RAVI ASHOKKUMAR AGRAWAL
05 Oct 2018
Director appointed
SHALINI RAVI AGRAWAL (Designated Partner)
Director appointed
PRIYANKA PRABHAT AGRAWAL (Designated Partner)
28 Jun 2018
Incorporated
Registered with Roc Ahmedabad
Director appointed
ASHOK KUMAR AGRAWAL (Designated Partner)
Director appointed
PRABHAT AGRAWAL (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); review board churn before relying on management continuity.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Bdh Industries L24100MH1990PLC059299 Mumbai, Maharashtra, India
Lividus Pharmaceuticals Private Limited U24239KL2008PTC022904 Karunagappally, Kerala, India
Archerchem U74999MH2017PLC295485 Mumbai, Maharashtra, India
Geeta Laboratories Private Limited U24230MH2002PTC135843 Mumbai, Maharashtra, India
Vibrant Pharmachem Private Limited U24231KA2009PTC050378 Raichur, Karnataka, India
Allozen Pharma Private Limited U24290KA2019PTC128784 Bangalore, Karnataka, India
Antila U24230GJ2010PTC063306 Ahmedabad, Gujarat, India
Stg Pharmagenerics Private Limited U51909MH2017FTC291263 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cubit Lifesciences before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cubit Lifesciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Cubit Lifesciences - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Cubit Lifesciences pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Cubit Lifesciences - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cubit Lifesciences an active company?

Cubit Lifesciences has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Cubit Lifesciences financially healthy?

Cubit Lifesciences has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Cubit Lifesciences?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cubit Lifesciences?

See the directors and ownership sections above for board and shareholding detail. 5 active director(s) are on record.

Does Cubit Lifesciences have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Cubit Lifesciences up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Cubit Lifesciences?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.